Eli Lilly and Company

Threat Mitigation Lead - Secure Software Development

United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Healthcare, Information SecurityIndustries

Requirements

Candidates should possess a Bachelor’s or Master’s degree in Computer Science, Information Security, or a related field, or equivalent practical experience. They must demonstrate experience working with cross-functional teams to reduce security risks and threats in applications and software. Strong problem-solving skills and the ability to address complex issues are essential, along with a focus on integrating security solutions into development and operational workflows.

Responsibilities

As the Threat Mitigation Lead, responsibilities include partnering with AppSec and cyber leadership to prioritize security threats, leading efforts to assess and mitigate risks through engagement with software development teams, guiding teams to address vulnerabilities, aiding in developing solutions to bring risks within acceptable levels, promoting secure coding practices throughout the SDLC, mentoring cross-functional teams, facilitating collaboration between teams, ensuring vulnerabilities are effectively tracked and managed, developing and refining threat mitigation strategies, providing regular updates on progress, and continuously improving threat mitigation processes and security integration.

Skills

Cyber Threat Mitigation
Secure Software Development
Risk Assessment
Vulnerability Management
Security Strategies
Cross-functional Collaboration
Secure Coding Practices
Threat Landscape Monitoring

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI